Insider Transactions in Q2 2021 at Arvinas, Inc. (ARVN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Ronald Peck Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-87.9%
|
$1,520,000
$76.69 P/Share
|
|
Jun 30
2021
|
Ronald Peck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+46.78%
|
$940,000
$47.38 P/Share
|
|
Jun 10
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
43,886
-1.71%
|
$3,554,766
$81.58 P/Share
|
|
Jun 10
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
43,886
+4.79%
|
$702,176
$16.0 P/Share
|
|
Jun 09
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
700
-0.08%
|
$56,000
$80.15 P/Share
|
|
Jun 09
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
700
+0.08%
|
$11,200
$16.0 P/Share
|
|
Apr 05
2021
|
Ian Taylor Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-8.61%
|
$1,650,000
$66.79 P/Share
|
|
Apr 05
2021
|
Ian Taylor Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.43%
|
$400,000
$16.0 P/Share
|